Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...
Paris is getting a sizzling new experience with the opening of the first French outpost of Benihana, the famed teppanyaki chain founded by the family of Steve Aoki, set catty-corner to the Louvre and ...